Overall Health, Not Just Age, is an Important Factor in Treatment of Non-Small Cell Lung Cancer

Two clinical studies highlight the importance of evaluating overall health instead of age in the management of lung cancer In fact younger patients with non-small cell lung cancer NSCLC are more likely to receive treatment than older patients regardless o [...]

Precision Cancer Medicine PARP Inhibitor Promising Treatment for Small Cell Lung Cancer

The results of a recent study published in The Journal of Clinical Oncology suggest the first new therapeutic option for Small Cell Lung Cancer SCLC in many years The study evaluated the addition of a novel precision cancer medicine called aPARP inhibitor [...]

Keytruda Trail Results Suggest Change in Management of Squamous Non-Small Cell Lung Cancer

An interim analysis of the phase III KEYNOTE-407 trial evaluated combined chemotherapy and immunotherapy showed a more than four-month longer median overall survival for metastatic squamous nonsmall-cell lung cancer NSCLC patients who received keytruda pe [...]